Adolescent Survivors of Cancer or Similar Illnesses

February 9, 2021 updated by: Memorial Sloan Kettering Cancer Center

Health Behaviors in Adolescent Survivors of Cancer or Similar Illnesses

The purpose of this study is to examine the health behaviors of young adults who have been treated for cancer, leukemia, or similar illnesses. We will also ask you some questions about your family members' and friends' health behaviors. We plan to use the findings from this study to design new programs to help teenage cancer survivors resist doing things that might harm their health.

Study Overview

Detailed Description

This study proposes to explore cancer-risk behaviors and future behavioral intentions among adolescent cancer survivors (i.e., 14-19 years old) and compare them to their "healthy" peers using population-based normative data. Additionally, it seeks to determine the significant theory-driven covariates related to adolescent survivors' health behaviors, which will aid in the design of future behavioral interventions.

Study Type

Observational

Enrollment (Anticipated)

148

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10065
        • Memorial Sloan Kettering Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Memorial Sloan-Kettering Cancer Center's Department of Pediatrics

Description

Inclusion Criteria:

  • Current age at enrollment between 14 and 19;
  • A diagnosis of cancer between the ages of 8 and 14;
  • At least 12 months post-treatment and no evidence of disease (NED) at the time of assessment;
  • Can be reached by mail or telephone;
  • Fluent in English;
  • Parent or legal guardian able to provide informed consent;
  • Able to provide informed assent.

Exclusion Criteria:

  • Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.
  • Currently receiving therapy for cancer treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Questionnaire or Interview
Complete a self-report survey once over the telephone or by mail. The questions are about your health beliefs and behaviors, your current health, and your mood. It should not take longer than 45 minutes to complete. About 15 of these people will participate in an additional, short audiotaped interview about sun protection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To describe the patterns of cancer-risk behaviors for adolescent cancer survivors as compared to population-based normative data of "healthy" adolescents, and to describe relevant theory-driven covariates for adolescent cancer survivors.
Time Frame: conclusion of study
conclusion of study

Secondary Outcome Measures

Outcome Measure
Time Frame
To examine the role and relative utility of sociodemographics, medical characteristics, theory-driven variables in explaining adolescent cancer survivors' health behaviors.
Time Frame: conclusion of study
conclusion of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marie Barnett, PhD, Memorial Sloan Kettering Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 22, 2004

Primary Completion (Actual)

February 8, 2021

Study Completion (Actual)

February 8, 2021

Study Registration Dates

First Submitted

December 20, 2007

First Submitted That Met QC Criteria

December 20, 2007

First Posted (Estimate)

December 24, 2007

Study Record Updates

Last Update Posted (Actual)

February 10, 2021

Last Update Submitted That Met QC Criteria

February 9, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 04-074

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Cancer Survivors

Clinical Trials on Questionnaire or Interview

3
Subscribe